MTFR1L: A Promising Drug Target for Neurodegenerative Diseases

Target Name: MTFR1L

NCBI ID: G56181

MTFR1L

MTFR1L: A Promising Drug Target for Neurodegenerative Diseases

Mitochondrial fission regulator 1-like (MTFR1L), also known as isoform a, is a protein that plays a crucial role in regulating mitochondrial fission, which is a critical process that generates energy in the form of ATP in the mitochondria. Mutations in the MTFR1L gene have been linked to a range of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. As a result, MTFR1L has emerged as a promising drug target for the development of new treatments for these debilitating conditions.

MTFR1L is a member of the Mitochondrial Complex (MC), a protein complex that includes over 20 different proteins that are involved in regulating mitochondrial function. The MC is responsible for regulating mitochondrial fission, which is the process by which the mitochondria fuse and divide to produce energy in the form of ATP. MTFR1L is one of the key proteins that is involved in this process.

MTFR1L is a 21-kDa protein that is expressed in most tissues of the body, including the brain. It is highly conserved, with only a few amino acid differences between the human MTFR1L gene and the mouse MTFR1L gene. The MTFR1L gene is located on chromosome 16q22 and has been implicated in a number of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Mutations in the MTFR1L gene have been linked to a range of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Studies have shown thatMTFR1L mutations are associated with decreased levels ofMTFR1L protein and increased levels of misfolded MTFR1L, which can lead to the formation of aggregates that are thought to contribute to the development of neurodegenerative diseases.

In addition to its role in regulating mitochondrial fission, MTFR1L has also been shown to play a number of other roles in the body. For example, MTFR1L has been shown to be involved in the regulation of cell apoptosis, which is the process by which cells die naturally in response to environmental stressors. MTFR1L has also been shown to be involved in the regulation of inflammation, which is a critical part of the immune system.

MTFR1L has also been shown to be involved in a number of other processes that are important for brain health, including the regulation of neurotransmitter release, the maintenance of cellular homeostasis, and the regulation of ion channels. It is also has been shown to be involved in the regulation of the production of reactive oxygen species (ROS), which can damage cellular components and contribute to the development of neurodegenerative diseases.

In conclusion, MTFR1L is a protein that plays a crucial role in regulating mitochondrial fission, which is a critical process that generates energy in the form of ATP in the mitochondria. Mutations in the MTFR1L gene have been linked to a range of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. As a result, MTFR1L has emerged as a promising drug target for the development of new treatments for these debilitating conditions. Further research is needed to fully understand the role of MTFR1L in the development and progression of neurodegenerative diseases, as well as to develop effective therapies that target this protein.

Protein Name: Mitochondrial Fission Regulator 1 Like

The "MTFR1L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTFR1L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets